Stage IA Breast Cancer Active Not Recruiting Phase 3 Trials for Exemestane (DB00990)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00066690Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerTreatment
NCT00310180Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)Treatment